In December 2010, the US Food and Drug Administration (FDA) notified its intention to get rid of the breast cancer indicator from bevacizumab, indicating that it had not been shown to be safe and helpful in breast cancer people.[38][39] The blended information from 4 diverse medical trials confirmed that bevacizumab https://gsk2643943a77543.xzblogs.com/70814113/2-nbdg-for-dummies